QJI — Interoperable Automated Glycemic Controller Class II
FDA product code QJI covers "Interoperable Automated Glycemic Controller", a Class II medical device regulated under 21 CFR 862.1356. Submissions are reviewed by the Clinical Chemistry panel. At least 20 recent 510(k) clearances have been granted under this product code.
Classification Details
- Product Code
- QJI
- Device Class
- Class II
- Regulation Number
- 862.1356
- Submission Type
- Review Panel
- CH
- Medical Specialty
- Clinical Chemistry
- Implant
- No
Definition
An interoperable automated glycemic controller is a device intended to automatically calculate drug doses based on inputs such as glucose and other relevant physiological parameters, and to command the delivery of such drug doses from a connected infusion pump. Interoperable automated glycemic controllers are designed to reliably and securely communicate with digitally connected devices to allow drug delivery commands to be sent, received, executed, and confirmed. Interoperable automated glycemic controllers are intended to be used in conjunction with digitally connected devices for the purpose of maintaining glycemic control.
Recent 510(k) Clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K261962 | medtronic minimed | SmartGuard Technology; Predictive Low Glucose Technology | July 9, 2026 |
| K261461 | insulet corporation | Omnipod 6 algorithm | June 29, 2026 |
| K260429 | tandem diabetes care | Control-IQ+ technology | April 24, 2026 |
| K253701 | medtronic minimed | SmartGuard Technology; Predictive Low Glucose Technology | February 3, 2026 |
| K253585 | medtronic minimed | SmartGuard technology; Predictive Low Glucose technology | January 14, 2026 |
| K251152 | diabeloop | DBLG2 | December 19, 2025 |
| K251779 | insulet corporation | Omnipod 5 algorithm | December 3, 2025 |
| K251217 | medtronic minimed | SmartGuard technology; Predictive Low Glucose technology | August 29, 2025 |
| K250798 | tandem diabetes care | Control-IQ+ technology | May 21, 2025 |
| K243823 | tandem diabetes care | Control-IQ+ technology | February 24, 2025 |
| K241777 | insulet corporation | SmartAdjust Technology | August 26, 2024 |
| K232741 | insulet corporation | SmartAdjust(TM) technology | May 29, 2024 |
| K232603 | camdiab | CamAPS FX | May 23, 2024 |
| K234055 | deka research and development | DEKA Loop | March 13, 2024 |
| K232382 | tandem diabetes care | Control-IQ Technology | November 3, 2023 |
| K232224 | beta bionics | iLet® Dosing Decision Software | September 22, 2023 |
| K220916 | beta bionics | iLet® Dosing Decision Software | May 19, 2023 |
| K203689 | tidepool project | Tidepool Loop | January 23, 2023 |
| K220394 | insulet corporation | SmartAdjust(TM) technology | August 19, 2022 |
| K203774 | insulet corporation | SmartAdjust technology | January 27, 2022 |